Next 10 |
2023-11-29 17:40:57 ET More on Timber Pharmaceuticals Timber Pharmaceuticals files for Chapter 11 in wake of failed merger Timber Pharma slips ahead of shareholder vote on merger Financial information for Timber Pharmaceuticals For further details see: Ti...
WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that...
WARREN, NJ - ( NewMediaWire ) - November 28, 2023 - Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, and its affiliated debtors and debtor-...
WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, and its affiliated d...
2023-11-21 12:43:52 ET Gainers: Safe and Green Development Corp SGD +42% . Anghami ( ANGH ) +42% . Addvantage Technologies Group ( AEY ) +35% . Symbotic SYM +36% . Safety Shot ( SHOT ) +34% . WaveDancer WAVD +23% . Direct Dig...
2023-11-17 17:44:09 ET More on Timber Pharmaceuticals Timber Pharma slips ahead of shareholder vote on merger Timber Pharmaceuticals announces NYSE acceptance of plan to regain listing compliance Seeking Alpha’s Quant Rating on Timber Pharmaceuticals H...
2023-11-17 10:00:08 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Curis, Emergen...
2023-11-16 11:32:04 ET More on Timber Pharma Timber Pharmaceuticals announces NYSE acceptance of plan to regain listing compliance Timber to be taken private by LEO Pharma, stock soars 100% Seeking Alpha’s Quant Rating on Timber Pharmaceuticals Histori...
WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orp...
NEW YORK, NY / ACCESSWIRE / August 30, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Hersha Hospitality Trust (NYSE:HT)'...
News, Short Squeeze, Breakout and More Instantly...
Timber Pharmaceuticals Inc. Company Name:
TMBR Stock Symbol:
NYSE Market:
Timber Pharmaceuticals Inc. Website:
WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that...
WARREN, NJ - ( NewMediaWire ) - November 28, 2023 - Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, and its affiliated debtors and debtor-...
WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, and its affiliated d...